CLINICAL EFFICACY AND SAFETY OF INSULIN ASPART COMPARED WITH REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS RECEIVING PRANDIAL INSULIN REGIMEN - A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Wojciechowski, P. [1 ]
Niemczyk-Szechowska, P. [1 ]
Olewinska, E. [1 ]
Jaros, P. [1 ]
Jurkiewicz, B. [2 ]
Skarzynska-Duk, J. [2 ]
Mlalecki, M. T. [3 ]
Rys, P. [1 ]
机构：
[1] HTA Consulting, Krakow, Poland
[2] Novo Nordisk Pharma, Warsaw, Poland
[3] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1390
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB4
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis
    V. Akbari
    F. Hendijani
    A. Feizi
    J. Varshosaz
    Z. Fakhari
    S. Morshedi
    S. A. Mostafavi
    Journal of Endocrinological Investigation, 2016, 39 : 215 - 225
  • [42] Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis
    Kumar, A. Sampath
    Maiya, Arun G.
    Shastry, B. A.
    Vaishali, K.
    Ravishankar, N.
    Hazari, Animesh
    Gundmi, Shubha
    Jadhav, Radhika
    ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2019, 62 (02) : 98 - 103
  • [43] COMPARATIVE EFFICACY AND SAFETY OF LIXISENATIDE AND INSULIN REGIMENS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Men, P.
    Qu, S.
    Luo, W.
    Liu, Y.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [44] A mufti-center efficacy and safety comparison of insulin aspart, human soluble insulin and human premix insulin,(70/30) in patients with type 2 diabetes mellitus
    Bretzel, RG
    Hirschberger, S
    Medding, J
    Linn, T
    DIABETES, 2002, 51 : A93 - A93
  • [45] Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
    Melo, Karla F. S.
    Bahia, Luciana R.
    Pasinato, Bruna
    Porfirio, Gustavo J. M.
    Martimbianco, Ana Luiza
    Riera, Rachel
    Calliari, Luis E. P.
    Minicucci, Walter J.
    Turatti, Luiz A. A.
    Pedrosa, Hermelinda C.
    Schaan, Beatriz D.
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (1):
  • [46] Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
    Karla F. S. Melo
    Luciana R. Bahia
    Bruna Pasinato
    Gustavo J. M. Porfirio
    Ana Luiza Martimbianco
    Rachel Riera
    Luis E. P. Calliari
    Walter J. Minicucci
    Luiz A. A. Turatti
    Hermelinda C. Pedrosa
    Beatriz D. Schaan
    Diabetology & Metabolic Syndrome, 11
  • [47] A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes
    Bretzel, RG
    Medding, J
    Arnolds, S
    Linn, T
    DIABETES CARE, 2004, 27 (05) : 1023 - 1027
  • [48] Meta-analysis of the insulin dosage in Chinese type 2 diabetes patients receiving insulin treatment
    Cai, Xiaoling
    Yang, Wenjia
    Gao, Xueying
    Zhou, Lingli
    Han, Xueyao
    Ji, Linong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S196 - S196
  • [49] Meta-analysis of the Insulin Dosage in Chinese Type 2 Diabetes Patients Receiving Insulin Treatment
    Cai, Xiaoling
    Yang, Wenjia
    Gao, Xueying
    Zhou, Lingli
    Han, Xueyao
    Ji, Linong
    DIABETES, 2016, 65 : A566 - A566
  • [50] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    DIABETOLOGIA, 2019, 62 : S10 - S11
12345